Halozyme Therapeutics shares owned by Wolverine Asset Management
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Wolverine Asset Management
from 13F filings
Historical chart of Wolverine Asset Management investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Wolverine Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by Wolverine Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $8.0M | 109k | 73.34 |
| 2025-06-30 | $2.9M | 55k | 52.02 |
| 2023-12-31 | $647k | 18k | 36.96 |
| 2023-09-30 | $684k | 18k | 38.20 |
| 2023-06-30 | $646k | 18k | 36.07 |
| 2021-06-30 | $38k | 843 | 45.08 |
| 2020-09-30 | $507k | 19k | 26.27 |
| 2020-06-30 | $568k | 21k | 26.79 |
More positions owned by Wolverine Asset Management
View all positions for Wolverine Asset Management